• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与新型 LIPA 变异相关的代谢相关脂肪性肝病。

A Form of Metabolic-Associated Fatty Liver Disease Associated with a Novel LIPA Variant.

机构信息

Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Department of Medical Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Arch Iran Med. 2023 Feb 1;26(2):86-91. doi: 10.34172/aim.2023.14.

DOI:10.34172/aim.2023.14
PMID:37543928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10685898/
Abstract

BACKGROUND

The LIPA gene on chromosome 10q23.31 contains 10 exons and encodes lipase A, the lysosomal acid lipase (LAL) containing 399 amino acids. Pathogenic variants in the LIPA result in autosomal recessive Wolman disease and cholesteryl ester storage disease (CESD). Here, we report a novel missense variant (NM_001127605.3:c.928T>A, p.Trp310Arg) of LIPA in an Iranian family with fatty liver disease identified by whole-exome sequencing and confirmed by Sanger sequencing.

METHODS

A 28-year-old woman referred with lean NASH cirrhosis and extremely high cholesterol levels. Fatty liver disease was found in six of her family members using vibration-controlled transient elastography (VCTE). Baseline routine laboratory tests were performed and whole-exome sequencing and confirmation by Sanger sequencing were done.

RESULTS

The index case had severe dyslipidemia and cirrhosis despite a body mass index of 21.09 kg/m . Six other family members had dyslipidemia and fatty liver or cirrhosis. A homozygous missense variant (NM_001127605.3:c.928T>A, p.Trp310Arg) of LIPA which caused LAL-D was found to be associated with fatty liver disease and/or cirrhosis.

CONCLUSION

A homozygous missense variant (NM_001127605.3:c.928T>A, p.Trp310Arg) of the LIPA gene which caused LAL-D was found to be associated with dyslipidemia, fatty liver disease and/or cirrhosis in six members of an Iranian family. These results should be confirmed by functional studies and extending the study to at least three families.

摘要

背景

10 号染色体 q23.31 上的 LIPA 基因包含 10 个外显子,编码含有 399 个氨基酸的溶酶体酸性脂肪酶(LAL)。LIPA 中的致病变体导致常染色体隐性遗传的沃曼病和胆固醇酯贮积症(CESD)。在这里,我们通过全外显子组测序在一个伊朗家族中报告了一种新型的 LIPA 错义变体(NM_001127605.3:c.928T>A,p.Trp310Arg),该变体导致脂肪性肝病,并通过 Sanger 测序得到确认。

方法

一名 28 岁女性因瘦型 NASH 肝硬化和胆固醇水平极高而就诊。使用振动控制瞬态弹性成像(VCTE)在其六名家族成员中发现了脂肪性肝病。进行了基线常规实验室检查,并进行了全外显子组测序和 Sanger 测序确认。

结果

尽管指数病例的体重指数为 21.09 kg/m ,但其患有严重的血脂异常和肝硬化。其他六名家族成员有血脂异常和脂肪肝或肝硬化。发现 LIPA 的一个纯合错义变体(NM_001127605.3:c.928T>A,p.Trp310Arg)与脂肪性肝病和/或肝硬化相关,该变体导致 LAL-D。

结论

在一个伊朗家族的六名成员中,发现 LIPA 基因的一个纯合错义变体(NM_001127605.3:c.928T>A,p.Trp310Arg)与血脂异常、脂肪性肝病和/或肝硬化相关。这些结果应通过功能研究和至少扩展到三个家族的研究来确认。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d1/10685898/fa9924e01929/aim-26-86-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d1/10685898/1d8c1ff2ad25/aim-26-86-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d1/10685898/fa9924e01929/aim-26-86-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d1/10685898/1d8c1ff2ad25/aim-26-86-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d1/10685898/fa9924e01929/aim-26-86-g002.jpg

相似文献

1
A Form of Metabolic-Associated Fatty Liver Disease Associated with a Novel LIPA Variant.一种与新型 LIPA 变异相关的代谢相关脂肪性肝病。
Arch Iran Med. 2023 Feb 1;26(2):86-91. doi: 10.34172/aim.2023.14.
2
The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.溶酶体酸性脂肪酶缺乏症的全球患病率和遗传谱:一种模仿 NAFLD 的罕见疾病。
J Hepatol. 2019 Jan;70(1):142-150. doi: 10.1016/j.jhep.2018.09.028. Epub 2018 Oct 11.
3
Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.溶酶体酸性脂肪酶缺乏症患者的识别与代谢谱分析。
J Clin Lipidol. 2015 Sep-Oct;9(5):716-26.e1. doi: 10.1016/j.jacl.2015.07.008. Epub 2015 Jul 26.
4
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study.LIPA 基因常见错义变异对脂肪性肝病及血脂表型的影响:单中心观察性研究的新视角。
Pharmacol Res Perspect. 2021 Oct;9(5):e00820. doi: 10.1002/prp2.820.
5
Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.溶酶体酸性脂肪酶缺乏症患者肝内胆固醇酯堆积:磁共振的非侵入性鉴定和治疗监测。
J Hepatol. 2013 Sep;59(3):543-9. doi: 10.1016/j.jhep.2013.04.016. Epub 2013 Apr 25.
6
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?溶酶体酸性脂肪酶活性降低:非酒精性脂肪性肝病临床连续谱中肝脏疾病严重程度的新标志物?
World J Gastroenterol. 2019 Aug 14;25(30):4172-4180. doi: 10.3748/wjg.v25.i30.4172.
7
Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.导致胆固醇酯贮积病(CESD)表型的人类溶酶体酸性脂肪酶基因(LIPA)突变的表达及功能特性
Protein Expr Purif. 2015 Jun;110:22-9. doi: 10.1016/j.pep.2014.12.009. Epub 2015 Jan 22.
8
Evaluation of 73 Enlisted Patients for Liver Transplant with Unknown Etiology Reveals a Late-Diagnosed Case of Lysosomal Acid Lipase Deficiency.对 73 名病因不明的入伍患者进行肝移植评估,发现一例迟发性溶酶体酸性脂肪酶缺乏症。
Int J Mol Sci. 2024 Aug 8;25(16):8648. doi: 10.3390/ijms25168648.
9
Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.儿童期起病溶酶体酸性脂肪酶缺乏症患者的分子和临床特征。回顾性研究、随访及两种新型 LIPA 致病性变异的检测。
Atherosclerosis. 2017 Oct;265:124-132. doi: 10.1016/j.atherosclerosis.2017.08.021. Epub 2017 Aug 26.
10
Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease.溶酶体脂肪酶缺乏症:十一例沃曼病或胆固醇酯贮积病患者的分子特征。
Mol Genet Metab. 2012 Mar;105(3):450-6. doi: 10.1016/j.ymgme.2011.12.008. Epub 2011 Dec 17.

引用本文的文献

1
Genetic and Lifestyle Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Relationship with Premature Coronary Artery Disease: A Study on the Pars Cohort.遗传和生活方式因素与代谢相关脂肪性肝病及其与早发冠心病的关系:帕斯卡队列研究。
Arch Iran Med. 2024 May 1;27(5):248-254. doi: 10.34172/aim.2024.36.

本文引用的文献

1
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date.PNPLA3 作为脂肪性肝病的治疗靶点:现有证据。
Expert Opin Ther Targets. 2021 Dec;25(12):1033-1043. doi: 10.1080/14728222.2021.2018418. Epub 2021 Dec 22.
2
Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa.代谢相关脂肪性肝病的命名与定义:中东和北非地区的共识
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):57-64. doi: 10.1016/S2468-1253(20)30213-2. Epub 2020 Nov 9.
3
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
4
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.2017 年全球疾病负担研究:1990-2017 年 195 个国家和地区按病因划分的肝硬化全球、区域和国家负担:系统分析。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.
5
Burden of Liver Diseases: A Review from Iran.肝病负担:来自伊朗的综述
Middle East J Dig Dis. 2019 Oct;11(4):189-191. doi: 10.15171/mejdd.2019.147. Epub 2019 Nov 5.
6
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology.遗传因素对非酒精性脂肪性肝病的影响:利用共同遗传学揭示系统生物学。
Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):40-52. doi: 10.1038/s41575-019-0212-0. Epub 2019 Oct 22.
7
The rising burden of non-communicable diseases in sub-Saharan Africa.撒哈拉以南非洲地区非传染性疾病负担日益加重。
Lancet Glob Health. 2019 Oct;7(10):e1295-e1296. doi: 10.1016/S2214-109X(19)30370-5.
8
Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report.一名溶酶体酸性脂肪酶缺乏症患者的临床结局及开始使用阿糖苷酶α治疗后的初步结果:病例报告
Mol Genet Metab Rep. 2019 Jun 18;20:100479. doi: 10.1016/j.ymgmr.2019.100479. eCollection 2019 Sep.
9
Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis?溶酶体酸性脂肪酶:能否成为隐匿性肝纤维化和肝硬化的新型非侵入性血清生物标志物?
Ann Hepatol. 2019 Jan-Feb;18(1):78-88. doi: 10.5604/01.3001.0012.7865.
10
VarSome: the human genomic variant search engine.VarSome:人类基因组变异搜索引擎。
Bioinformatics. 2019 Jun 1;35(11):1978-1980. doi: 10.1093/bioinformatics/bty897.